Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Contract Research Organization (CRO) Services Market worth $140.32 billion by 2031 | MarketsandMarkets™

prnewswire.com
IQV Mentioned as a top company in the growing CRO services market, indicating potential for continued business but no specific positive or negative news. LH Listed as a major player in the CRO services market, which is projected to grow significantly. No specific performance indicators are provided. TMO Identified as a leading company in the CRO services sector, which is experiencing market growth. The article does not provide specific details about TMO's performance. CSTL Included as a top company in the CRO services market, which is forecast for substantial growth. The article does not offer specific insights into Charles River Laboratories' current standing.

Contract Research Organization (CRO) Services Market worth $140.32 billion by 2031 | MarketsandMarkets™ DELRAY BEACH, Fla., April 30, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Contract Research Organization (CRO) Services Market is projected to grow from about USD 93.02 billion in 2026 to USD 140.32 billion by 2031, at a CAGR of 8.6%.

Browse 650 market data Tables and 57 Figures spread through 450 Pages and in-depth TOC on 'Contract Research Organization (CRO) Services Market - Global Forecast to 2031'

Contract Research Organization (CRO) Services Market Size & Forecast:

Contract Research Organization (CRO) Services Market Trends & Insights:

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167410116

The factors driving the market growth include the increasing complexity and volume of trials; the growing focus on patient-centric clinical trials, such as Decentralized Clinical trials (DCTs); and the flexibility of services offered by CROs. Moreover, the upcoming patent cliff for therapeutic drugs is prompting pharmaceutical companies to invest heavily in R&D and to outsource their clinical trials to CROs. Additionally, the growing regulatory focus on patient diversity and data analysis offerings that favor customer reimbursement & marketing access strategies are key opportunities for market players. However, challenges associated with the cybersecurity of patient data, sponsors' intellectual property, and patient retention during trials hinder the market's growth to some extent.

By modality, the medical devices segment is estimated to register the highest CAGR during the forecast period.

The CRO services market is segmented into small molecules, biologics, medical devices, and biosimilars. The biologics segment is projected to register the highest CAGR during the forecast period. This strong growth is attributed to the rapid expansion of biologics in the pharmaceutical industry and the rising development activity across monoclonal antibodies, recombinant proteins, vaccines, and other complex biologic therapies, all of which require specialized development and testing support. In addition, sponsors are increasingly outsourcing biologics development to improve speed, flexibility, and cost efficiency, further supporting the growth of this segment in the global CRO services market.

Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=167410116

By end user, the medical device companies' segment is expected to grow at the highest CAGR during the forecast period.

The CRO services market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes. The medical device companies' segment is expected to grow at the fastest rate, owing to the increasing complexity and regulatory requirements associated with device development and approval, which are fueling demand for specialized CRO expertise to accelerate time-to-market. Additionally, many medical device companies are mid-sized or emerging players that lack in-house infrastructure for large-scale trials, making CRO partnerships a cost-effective solution.

The Asia Pacific region is expected to register the highest CAGR during the forecast period.

Based on the region, the CRO Services market is segmented into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is expected to register the highest growth rate during the forecast period, owing to the presence of high-growth hotspots such as India, China, and Japan that are focused on advancing research capabilities. The growing prevalence of chronic diseases has further fueled the need to outsource clinical services & research activities to CROs, thereby supporting market growth in this region during the forecast period.

Inquire Before Buying @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=167410116

Top Companies in Contract Research Organization (CRO) Services Market:

The Top Companies in Contract Research Organization (CRO) Services Market include IQVIA Inc. (US), Laboratory Corporation of America Holdings (US), Thermo Fisher Scientific Inc. (US), ICON Plc (Ireland), WuXi AppTec (China), Syneos Health (US), and Charles River Laboratories (US), among others.

Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting

Related Reports:

Biologics Safety Testing Market - Global Forecast to 2029

Laboratory Software Market - Global Forecast to 2030

Clinical Trial Supplies Market - Global Forecast to 2030

Vaccines Market - Global Forecast to 2031

Clinical Trial Services Market - Global Forecast to 2030

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets™ INC.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA: +1-888-600-6441

Email: [email protected]

Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/5909825/MarketsandMarkets_Logo.jpg

SOURCE MarketsandMarkets